Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Deloitte
Mallinckrodt
Citi
Cantor Fitzgerald
Accenture
Harvard Business School
Julphar
McKesson

Generated: December 13, 2018

DrugPatentWatch Database Preview

EUCRISA Drug Profile

« Back to Dashboard

Which patents cover Eucrisa, and what generic alternatives are available?

Eucrisa is a drug marketed by Anacor Pharms Inc and is included in one NDA. There are four patents protecting this drug.

This drug has one hundred and eleven patent family members in twenty-two countries.

The generic ingredient in EUCRISA is crisaborole. One supplier is listed for this compound. Additional details are available on the crisaborole profile page.

Summary for EUCRISA
Drug patent expirations by year for EUCRISA
Generic Entry Opportunity Date for EUCRISA
Generic Entry Date for EUCRISA*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
OINTMENT;TOPICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for EUCRISA
Synonyms for EUCRISA
1073669-75-6
1187189-21-4
4-((1-HYDROXY-1,3-DIHYDROBENZO-[C][1,2]OXABOROL-5-YL)OXY)BENZONITRILE
4-((1-Hydroxy-1,3-dihydrobenzo(c)(1,2)oxaborol-6-yl)oxy)benzonitrile
4-((1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile
4-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yloxy)benzonitrile
4-[(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy]benzonitrile
4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy]benzonitrile
4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]benzonitrile
5-(4-cyanophenoxy)-1-hydroxy-2,1-benzoxaborole
5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole
5098AC
906673-24-3
ABP001114
AK102641
AKOS016005425
AN 2728
AN-2728
AN2728
ANW-65536
API0013781
AX8234180
BC245091
BDBM50277665
Benzonitrile, 4-((1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy)-
Benzonitrile, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-
C14H10BNO3
CHEBI:134677
CHEMBL484785
compound 5b [PMID: 19303290]
Crisaborole
Crisaborole (USAN/INN)
Crisaborole [USAN:INN]
Crisaborole topical ointment 2%
Crisaborole, >=98% (HPLC)
Crisaborole(AN-2728)
CS-1057
CTK8C0958
D0SM0W
D10873
DB-078771
DB05219
DTXSID10238231
Eucrisa (TN)
EX-A1087
FT-0767999
GTPL9151
HE053309
HE268247
HY-10978
KB-40872
KS-0000063U
MFCD17169940
MolPort-023-332-548
NCGC00345792-01
Q2R47HGR7P
SCHEMBL595261
ST24042710
TC-154281
UNII-Q2R47HGR7P
USZAGAREISWJDP-UHFFFAOYSA-N
W-5676
ZINC169748244

US Patents and Regulatory Information for EUCRISA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Covington
Julphar
Argus Health
Mallinckrodt
Farmers Insurance
Colorcon
McKinsey
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.